News

03/08/2010 - Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis™ Personalized Immunotherapy Platform


Read More »

03/05/2010 - Achillion to Present at Upcoming Investor Conferences


Read More »

03/04/2010 - Argos Therapeutics Publishes Positive Immune Response, Safety and Manufacturing Data for its Arcelis™ HIV Program in Clinical Immunology


Read More »